ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,306Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 972

$954K Total Retail Price of All Prescriptions

Rank: 77 out of 972

487 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 487 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 487 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 13,877 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 643 599 1 2
FUROSEMIDE 590 539 2 7
OMEPRAZOLE 466 374 3 5
POTASSIUM CHLORIDE 429 379 4 13
WARFARIN SODIUM 422 402 5 12
AMLODIPINE BESYLATE 407 383 6 4
LISINOPRIL 389 330 7 1
HYDROCODONE-ACETAMINOPHEN 356 320 S3 8 6
METFORMIN HCL 352 285 9 8
LEVOTHYROXINE SODIUM 273 227 10 3
METOPROLOL SUCCINATE 247 221 11 16
MELOXICAM 236 175 12 36
NEXIUM 230 185 13 30
RANITIDINE HCL 226 162 14 24
DONEPEZIL HCL 226 226 14 26
ATORVASTATIN CALCIUM 220 193 16 11
POLYETHYLENE GLYCOL 3350 212 152 17 67
NAMENDA 208 208 18 38
METOPROLOL TARTRATE 207 174 19 9
PREDNISONE 198 182 20 40
HYDROCHLOROTHIAZIDE 181 170 21 10
CYMBALTA 172 159 22 49
CARVEDILOL 168 152 23 21
ATENOLOL 163 150 24 18
TAMSULOSIN HCL 161 137 25 29
LOSARTAN POTASSIUM 160 160 26 17
LOVASTATIN 154 129 27 22
CRESTOR 149 118 28 33
TRIAMTERENE-HYDROCHLOROTHIAZID 134 118 29 152
PANTOPRAZOLE SODIUM 132 120 30 41
CLOPIDOGREL 128 119 31 37
CITALOPRAM HBR 118 93 32 19
TRAMADOL HCL 118 98 32 15
GLIMEPIRIDE 115 114 34 34
ADVAIR DISKUS 114 101 35 45
DIOVAN 112 101 36 48
ALLOPURINOL 108 94 37 28
FENTANYL 103 91 S2 38 89
HALOPERIDOL 101 101 39 168
GABAPENTIN 97 87 40 14
PLAVIX 92 82 41 55
AMLODIPINE BESYLATE-BENAZEPRIL 91 81 42 114
SPIRONOLACTONE 90 80 43 54
METOCLOPRAMIDE HCL 89 46 44 138
IPRATROPIUM-ALBUTEROL 87 59 45 132
FENOFIBRATE 87 77 45 66
ZOLPIDEM TARTRATE 83 66 47 23
CELEBREX 81 78 48 85
TRAMADOL HCL-ACETAMINOPHEN 81 66 48 155
CLONIDINE HCL 77 74 50 57
FLUDROCORTISONE ACETATE 75 68 51 380
ALENDRONATE SODIUM 75 74 51 27
RAMIPRIL 73 57 53 101
ESCITALOPRAM OXALATE 72 54 54 65
BISOPROLOL-HYDROCHLOROTHIAZIDE 72 56 54 166
KLOR-CON M20 71 60 56 78
LANSOPRAZOLE 69 61 57 210
BENAZEPRIL HCL 69 69 57 88
CIPROFLOXACIN HCL 68 61 59 63
VENLAFAXINE HCL ER 67 41 60 107
DILTIAZEM 24HR CD 67 55 60 74
OXYBUTYNIN CHLORIDE ER 66 53 62 128
AVODART 64 64 63 214
SPIRIVA 64 52 63 56
DILTIAZEM ER 64 59 63 129
DIVALPROEX SODIUM 62 26 66 96
COMBIVENT 62 24 66 94
ALBUTEROL SULFATE 62 13 66 169
BUPROPION XL 61 52 69 191
PRAVASTATIN SODIUM 61 57 69 20
PEN NEEDLE 60 54 71 99
ACTOS 59 48 72 163
SINGULAIR 58 40 73 81
DOXYCYCLINE HYCLATE 57 54 74 117
ROPINIROLE HCL 56 26 75 72
ENABLEX 56 55 75 204
LANTUS 56 56 75 44
BYSTOLIC 55 47 78 102
DIGOXIN 55 55 78 52
PAROXETINE HCL 52 44 80 64
NAPROXEN 52 37 80 71
LOSARTAN-HYDROCHLOROTHIAZIDE 51 45 82 61
FINASTERIDE 50 50 83 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 2, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.